Cargando…

Prognostic Value of Serum Exosomal AHCY Expression in Hepatitis B-Induced Liver Cirrhosis

Objective: We aimed to investigate serum exosomal adenosylhomocysteinase (AHCY) expression in hepatitis B-induced liver cirrhosis (HBV-LC) patients and to determine the prognostic value of serum exosomal AHCY. Methods: We collected serum samples from 100 patients with chronic hepatitis B (CHB) and f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Ling, Yan, Cuilin, Wang, Minjie, Yang, Jiajia, Wang, Hongmei, Wang, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606640/ https://www.ncbi.nlm.nih.gov/pubmed/34820406 http://dx.doi.org/10.3389/fmed.2021.777452

Ejemplares similares

Functional and Pathological Roles of AHCY
por: Vizán, Pedro, et al.
Publicado: (2021)

Exosomal circ‐AHCY promotes glioblastoma cell growth via Wnt/β‐catenin signaling pathway
por: Li, Yuhui, et al.
Publicado: (2023)

The values of AHCY and CBS promoter methylation on the diagnosis of cerebral infarction in Chinese Han population
por: Li, Xiaodong, et al.
Publicado: (2020)

DNA methylation of AHCY may increase the risk of ischemic stroke
por: Zhao, Lei, et al.
Publicado: (2020)

Serum Metabolomic Analysis of Chronic Drug-Induced Liver Injury With or Without Cirrhosis
por: Chen, Shuai-shuai, et al.
Publicado: (2021)

The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma
por: Shen, Jiliang, et al.
Publicado: (2017)

Chromatin capture links the metabolic enzyme AHCY to stem cell proliferation
por: Aranda, Sergi, et al.
Publicado: (2019)

Tissue-specific down-regulation of S-adenosyl-homocysteine via suppression of dAhcyL1/dAhcyL2 extends health span and life span in Drosophila
por: Parkhitko, Andrey A., et al.
Publicado: (2016)

Signature literature review reveals AHCY, DPYSL3, and NME1 as the most recurrent prognostic genes for neuroblastoma
por: Chicco, Davide, et al.
Publicado: (2023)

Abnormal Hypermethylation at Imprinting Control Regions in Patients with S-Adenosylhomocysteine Hydrolase (AHCY) Deficiency
por: Motzek, Antje, et al.
Publicado: (2016)

Metabolomic Signatures of Autoimmune Hepatitis in the Development of Cirrhosis
por: Li, Shan-shan, et al.
Publicado: (2021)

The Role of Exosomes in Viral Hepatitis and Its Associated Liver Diseases
por: Zhou, Hao, et al.
Publicado: (2021)

Prognostic assessment of liver cirrhosis and its complications: current concepts and future perspectives
por: Gülcicegi, Dilan Elcin, et al.
Publicado: (2023)

Knock-down of AHCY and depletion of adenosine induces DNA damage and cell cycle arrest
por: Belužić, Lucija, et al.
Publicado: (2018)

Prognostic value of serum lactate kinetics in critically ill patients with cirrhosis and acute-on-chronic liver failure: a multicenter study
por: Gao, Feng, et al.
Publicado: (2019)

Enlargements of the Liver.—IV: Cirrhosis of the Liver
Publicado: (1910)

Precipitating Factors and Treatment Outcomes of Hepatic Encephalopathy in Liver Cirrhosis
por: Poudyal, Nandu S, et al.
Publicado: (2019)

In Every Man, There Is a Child: Henoch-Schönlein Purpura in an Adult With Liver Cirrhosis
por: Yang, Jiajia, et al.
Publicado: (2021)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Efficacy and Safety of Treatments for Patients With Portal Hypertension and Cirrhosis: A Systematic Review and Bayesian Network Meta-Analysis
por: Yao, Qigu, et al.
Publicado: (2021)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Enlargements of the Liver.—V: Cirrhosis (Continued)
Publicado: (1910)

Enlargements of the Liver.—VI: Cirrhosis (concluded)
Publicado: (1910)

Serum zonulin levels in patients with liver cirrhosis: Prognostic implications
por: Voulgaris, Theodoros A, et al.
Publicado: (2021)

Serum CXCL1 Is a Prognostic Factor for Patients With Hepatitis B Virus–Related Acute-On-Chronic Liver Failure
por: Xiao, Lanlan, et al.
Publicado: (2021)

Hereditary Spherocytosis With Liver Transplantation After Cirrhosis: A Case Report
por: Yang, Xueliang, et al.
Publicado: (2022)

The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis
por: Kang, Seong Hee, et al.
Publicado: (2018)

Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery
por: Cizmic, Amila, et al.
Publicado: (2023)

Diagnostic Value of Hepatic Vein Ultrasound in Early Detection of Liver Cirrhosis
por: Zare Marzouni, Hadi, et al.
Publicado: (2018)

Liver Stiffness Is a Predictor of Rebleeding in Patients With Hepatitis B-Related Cirrhosis: A Real-World Cohort Study
por: Liu, Linxiang, et al.
Publicado: (2021)

Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy
por: Kim, Mo-Jong, et al.
Publicado: (2023)

Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis
por: Abu Omar, Yazan, et al.
Publicado: (2019)

Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis
por: Xia, Xiaoxue, et al.
Publicado: (2018)

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
por: Sauerbruch, Tilman, et al.
Publicado: (2023)

Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota
por: Xu, Jia-qi, et al.
Publicado: (2023)

The Prognostic Value of Serum HBV-RNA during Hepatitis B Virus Infection is Related to Acute-on-Chronic Liver Failure
por: Qian, Keli, et al.
Publicado: (2022)

Roles of Macrophages and Exosomes in Liver Diseases
por: Shen, Mengyi, et al.
Publicado: (2020)

An Immune Signature Robustly Predicts Clinical Deterioration for Hepatitis C Virus-Related Early-Stage Cirrhosis Patients
por: Guo, Cheng, et al.
Publicado: (2021)

Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis
por: Wu, Cheng, et al.
Publicado: (2015)

The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular Carcinoma
por: Zhang, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rkud6jg62lomquacpdq9tc7qrr